1323485-71-7

Basic information

• Product Name: Edaravone iMpurity P3
• Synonyms: Edaravone iMpurity P3;4,5-dihydro-a,a,3-triMethyl-5-oxo-1-phenyl- 1H-Pyrazole-4-Methanesulfonic acid;2-(3-Methyl-5-oxo-1-phenyl-4,5-dihydro-1H-pyrazol-4-yl)propane-2-sulfonic acid;4,5-Dihydro-alpha,alpha,3-trimethyl-5-oxo-1-phenyl-1H-pyrazole-4-methanesulfonic acid;Edaravone P3;Edaravone P3 Impurity;2-(5-hydroxy-3-methyl-1-phenyl-1Hpyrazol-4-yl)propane-2-sulfonic acid
• CAS NO: 1323485-71-7
• Molecular Formula: C13H16N2O4S
• Molecular Weight: 296.34214
• EINECS: -0
• Mol File: 1323485-71-7.mol
• Article Data: 0

Chemical Properties

• Appearance: /
• Density: 1.35±0.1 g/cm3 (20 ºC 760 Torr)
• PKA: 0.73±0.50(Predicted)
• CAS DataBase Reference: Edaravone iMpurity P3(CAS DataBase Reference)
• NIST Chemistry Reference: Edaravone iMpurity P3(1323485-71-7)
• EPA Substance Registry System: Edaravone iMpurity P3(1323485-71-7)

Safety Data

• Hazardous Substances Data: 1323485-71-7(Hazardous Substances Data)

Usage

Uses

2-?(3-?Methyl-?5-?oxo-?1-?phenyl-?4,?5-?dihydro-?1h-?pyrazol-?4-?yl)?propane-?2-?sulfonic Acid is an impurity of Edaravone (E335000) which inhibits the disease activity in rheumatoid arthritis. Edaravone can significantly enhance IR flap viability and protect flap vessels, which is related to scavenging oxygen free radicals, reducing the consumption of SOD, reducing the extent of lipid peroxidation and inflammation, and protecting functional structure of vessels in the early stages of reperfusion.